AMEX · Healthcare · Biotechnology
Nasus Pharma Ltd.
NSRX
Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. CEO Dan Teleman · Market cap $25.9M.
$3.01
+0.01 · +0.50%
52w hi $9.9952w lo $1.98
Off 52w high 64.0%
67
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Hold
Avg PT $22.00
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 31 | Dan Benjamin Teleman | Chief Executive Officer | Buy | 15,000 | $2.04 | +$31K | 67 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay